Mayne Pharma Group Limited (ASX: MYX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Mayne Pharma Group Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Mayne Pharma Group Limited (ASX: MYX)
Latest News
Share Fallers
Mayne Pharma share price crashes 13% lower on market update
Share Fallers
Why Ainsworth Game Technology, GrainCorp, HUB24, & Mayne Pharma dropped lower today
Share Gainers
ALL ORDINARIES finishes higher Friday: 8 shares you missed
⏸️ ASX Shares
Mayne Pharma posts 35% increase in underlying half year profit
Share Market News
5 things to watch on the ASX 200 on Friday
⏸️ ASX Shares
10 things that could affect ASX shares and your portfolio in 2019
Share Gainers
ALL ORDINARIES finishes higher Wednesday: 8 shares you missed
Share Market News
Mayne Pharma launches Tolsura in US
Share Gainers
Top broker rates Mayne Pharma shares as a buy: Should you invest?
Share Gainers
Why MOD Resources, Mayne Pharma, Super Retail, & Syrah shares surged higher today
Share Fallers
Why Ausdrill, Kogan, Mayne Pharma, & Retail Food Group shares are sliding lower today
Share Fallers
Why the Mayne Pharma share price is sinking again today
Frequently Asked Questions
-
Mayne Pharma made a fully franked cash payment to shareholders in January 2023. Prior to that, the company’s last dividend payout was in 2011.
-
Mayne Pharma Group Ltd listed on the ASX on 29 June 2007.
MYX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Mayne Pharma Group Limited
Mayne Pharma Group Ltd (ASX: MYX) is a specialty pharmaceutical company focused on commercialising branded and generic pharmaceutical products. Its South Australian manufacturing base produces a portfolio of oral and topical products including tablets, powders, capsules, liquids, and creams.
Mayne Pharma performs limited research and development, typically acquiring off-patent or tail-end pharmaceutical brands. The company also has a contract manufacturing segment and advertises its services in assisting other drug developers in getting their products to market. The Group earns more than 90% of its revenue from the US market.
